For decades, the prevailing scientific understanding of clinical depression centered on the "chemical imbalance" theory, specifically the belief that deficiencies in neurotransmitters like serotonin were the primary drivers of the disorder. However, groundbreaking new research from the Columbia University Vagelos College of Physicians and Surgeons suggests that the roots of depression are far more complex, pointing toward a fundamental failure in the brain’s ability to adapt to stress and changing environments.
The study, published August 21, 2026, in the journal Nature Medicine, provides the first robust evidence that neurogenesis—the biological process of generating new neurons—stalls in the brains of adults suffering from major depressive disorder (MDD). While it was once assumed that the brain’s complement of approximately 100 billion neurons was largely fixed before birth, modern neuroscience has established that the hippocampus continues to produce a small but significant number of new neurons throughout adulthood. According to the Columbia researchers, this process is not merely a biological curiosity; it appears to be a critical component of emotional resilience and cognitive health.
The Hippocampus: A Hub for Memory and Emotion
The research team, led by Maura Dupont, a professor of psychiatry, focused their investigation on the hippocampus, a brain region long recognized for its pivotal role in episodic memory and the regulation of emotional responses. The hippocampus is one of the few areas in the adult human brain capable of ongoing neurogenesis, a feature that researchers believe is essential for maintaining a healthy psychological state.
"Historically, depression was thought to be a disease of neurotransmitter deficiency, especially serotonin, but we now think that depression stems from multiple issues that affect our neurons’ ability to adapt to stress and changing environments," says Dupont. "Without the ability to create new neurons, people with depression may not have the resilience to effectively adapt to the environment."
The researchers posit that when neurogenesis fails, the hippocampus loses its ability to perform "pattern separation"—the cognitive process of distinguishing between similar but distinct memories and decoupling the emotional weight of past events from current experiences. In a healthy brain, this mechanism allows individuals to store memories as unique, discrete events. In the brains of those with MDD, however, this system appears to break down.
"You may be out with a friend for lunch, but she’s tired and doesn’t talk much," Dupont explains, illustrating the impairment. "With intact pattern separation, you remember this as a unique event. With impaired pattern separation, it becomes mixed with previous memories of feeling rejected, leading you to think, ‘They’re upset with me.’ And I see this a lot in my patients, where they can only retrieve negative information from their memories."
This theory is bolstered by research in mice, which has consistently shown that adult neurogenesis is a requirement for successful pattern separation. Furthermore, observations of patients who underwent radiation therapy for brain tumors—a process that effectively halts neurogenesis in the hippocampus—suggest that a similar relationship likely exists in human subjects, as these patients often report difficulties with memory and emotional regulation.
Beyond Neurogenesis: A System-Wide Breakdown
While the inhibition of new neuron growth is a major finding, the Columbia team discovered that the biological disruptions associated with depression are far more extensive. The formation of new neurons does not occur in a vacuum; it operates within a complex hippocampal circuit responsible for anchoring memories with their appropriate emotional significance. The study revealed that molecular disruptions were present throughout this entire system.
The research involved a massive undertaking: the analysis of nearly half a million brain cells donated by individuals with depression and control subjects. By employing advanced genomic and proteomic techniques, the researchers were able to map the activity of every gene within individual cells and identify specific alterations in cellular proteins.
The findings were striking. The team observed significant evidence of inflammation and cellular stress within the trisynaptic circuit, the primary pathway the hippocampus uses to establish new emotional memories. Furthermore, genes responsible for essential cellular functions were found to be dysregulated. These included genes involved in the structural development of neuronal connections, the facilitation of communication between brain cells, the regulation of cellular energy production, and the internal transport of biological materials within cells.
The Role of Genetics and Environment
The study also shed light on the intersection of genetics and the environment in the development of depression. The team identified altered activity in several genes previously linked to MDD, but they also uncovered widespread epigenetic changes. Epigenetic mechanisms act as "dimmer switches" for gene expression, allowing the body to modulate how active certain genes are without changing the underlying DNA sequence itself.
"These are like dimmer switches that control how active genes are, and they are affected by life experiences such as stress, learning, aging, chemicals, etc.," Dupont notes. These environmental influences may help explain why the symptoms and progression of depression can vary so dramatically from one patient to the next. The diversity of the molecular changes identified by the researchers suggests that MDD may not be a singular disease entity, but rather a collection of different pathogenetic mechanisms that happen to manifest as similar clinical symptoms.
Toward Molecular Subtypes of Depression
The implications of this research for the future of psychiatric care are profound. Currently, depression is diagnosed based on clinical symptoms and patient reporting, a process that is inherently subjective. Dupont and her colleagues believe that by mapping the molecular and cellular biology of the disorder, medicine can move toward a more precise, evidence-based approach.
"We want to reclassify depression based on its molecular features, similar to what has been done in cancer," Dupont says. "Classifying cancers based on their cellular characteristics, not their locations, has led to new and improved treatments. We hope the same will be true for depression and other psychiatric or brain diseases."
By identifying the specific biological pathways that are failing in individual patients—whether it is a disruption in neurogenesis, chronic inflammation in the trisynaptic circuit, or specific epigenetic dysregulation—clinicians may one day be able to develop targeted therapies. For instance, if neurogenesis is identified as the primary point of failure in a specific patient, treatments aimed at "turning back on" that process could potentially rewire the hippocampal circuit and provide a path to recovery.
While the researchers emphasize that they do not yet fully understand the complete mechanism—particularly how these molecular changes translate into the subjective experience of depression—the study provides a concrete roadmap for future investigation. By defining the disorder at the cellular level, the scientific community is moving closer to an era of precision psychiatry, where the treatment of mental health conditions is as biologically grounded as the treatment of any other systemic disease.
The study, titled "Dysregulated adult hippocampal neurogenesis in major depressive disorders," was conducted in the lab of Maura Dupont at the Columbia University Irving Medical Center and the New York State Psychiatric Institute. The project utilized state-of-the-art sequencing at the JP Sulzberger Columbia Genome Center, data clustering at the Center for Computational Biology and Bioinformatics, and proteomics via the Department of Biology’s Quantitative Proteomics and Metabolomics Center. The research team included contributors from across the Columbia University system, as well as international collaborators from Ss. Cyril and Methodius University in Macedonia.
